Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 377.48B | 377.48B | 356.01B | 339.66B | 340.80B | 338.46B |
Gross Profit | 107.55B | 105.84B | 100.95B | 102.26B | 100.13B | 99.81B |
EBITDA | 15.53B | 12.31B | 15.09B | 13.32B | 11.10B | 13.64B |
Net Income | 3.61B | 3.61B | 6.19B | 4.71B | 3.83B | 5.85B |
Balance Sheet | ||||||
Total Assets | 187.26B | 187.26B | 156.27B | 152.97B | 152.09B | 144.26B |
Cash, Cash Equivalents and Short-Term Investments | 4.37B | 4.37B | 3.84B | 3.90B | 3.77B | 6.30B |
Total Debt | 46.44B | 46.44B | 29.09B | 29.63B | 35.53B | 19.93B |
Total Liabilities | 114.20B | 114.20B | 84.61B | 85.81B | 88.02B | 82.39B |
Stockholders Equity | 73.06B | 73.06B | 71.67B | 67.16B | 64.08B | 61.87B |
Cash Flow | ||||||
Free Cash Flow | -5.03B | -4.94B | 4.04B | 6.19B | -12.79B | 6.90B |
Operating Cash Flow | 12.87B | 12.87B | 12.23B | 14.88B | 868.00M | 13.68B |
Investing Cash Flow | -34.00B | -34.00B | -7.86B | -8.81B | -13.53B | -7.05B |
Financing Cash Flow | 21.67B | 21.67B | -4.43B | -5.94B | 10.13B | -4.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥108.49B | 11.51 | 2.15% | 4.99% | 23.63% | ||
68 Neutral | ¥232.52B | 19.36 | 2.81% | 18.53% | -36.19% | ||
65 Neutral | ¥129.33B | 39.67 | 1.73% | 7.54% | -47.00% | ||
62 Neutral | ¥100.71B | 16.35 | 1.55% | 4.66% | 3.70% | ||
62 Neutral | ¥188.96B | 187.65 | 1.67% | 23.04% | ― | ||
61 Neutral | $17.96B | 13.14 | -5.29% | 3.00% | 1.25% | -13.95% | |
61 Neutral | ¥175.36B | 35.97 | 1.49% | 1.54% | -15.67% |